Table 2.
APOE genotype frequency and baseline plasma cholesterol and triacylglycerol levels
| Frequency (%) | Total C | LDL-C | HDL-C | Triacylglycerol | |
|---|---|---|---|---|---|
| E2/E3 | 11 | 5.1 ± 1.04a) | 3.5 ± 0.87 | 1.3 ± 0.25 | 1.5 ± 0.63 |
| E2/E4 | 2 | 5.3 ± 0.86 | 3.5 ± 0.21 | 1.5 ± 0.66 | 1.4 ± 0.43 |
| E3/E3 | 55 | 6.2 ± 0.86 | 4.3 ± 0.75 | 1.6 ± 0.31 | 1.2 ± 0.43 |
| E3/E4 | 28 | 6.2 ± 0.97 | 4.3 ± 0.75 | 1.6 ± 0.41 | 1.4 ± 0.64 |
| E4/E4 | 4 | 7.0 ± 0.91b) | 5.0 ± 0.87b) | 1.7 ± 0.22 | 1.3 ± 0.65 |
a)
All values are means ± SD.
b)
E4/E4 genotypes have significantly greater Total-C and LDL-C than E2/E3 genotypes [p = 0.001, ANOVA].